4 drug, devicemakers in the headlines

Here are four drug and medical device companies that made headlines in the past week.

1. Baxter recalls frozen Intralipid shipment: 4 things to know
Baxter International on Thursday recalled one shipment of Intralipid due to temperature control issues.

2. Jury orders AbbVie to pay $140M+ for misrepresenting testosterone drug risks
AbbVie must pay more than $140 million to a Tennessee man who says he experienced a heart attack after taking the company's testosterone replacement drug AndroGel, a federal jury ruled Oct. 5.

3. J&J exits insulin pump business: 4 things to know
Johnson & Johnson's insulin pump unit, Animas Corp., will shutter business operations in the U.S. and Canada, effective immediately.  

4. Medtronic estimates $250M earnings loss from Hurricane Maria: 4 things to know
Medtronic expects supply chain disruptions caused by Hurricane Maria to cost the company up to $250 million in the second quarter of fiscal year 2018, which ends Oct. 27.

Copyright © 2023 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars